INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Apr 15, 2021 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 5,383 | -- | -- |
Feb 23, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
Feb 23, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 248,079 | -- | -- |
Dec 30, 2020 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 158,079 | -- | -- |
Nov 16, 2020 |
EVP Research
Trans History: 222
|
EVP Research | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,736 | -- | -- |
Oct 22, 2020 |
EVP Research
Trans History: 222
|
EVP Research | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,264 | -- | -- |
Oct 22, 2020 |
EVP Research
Trans History: 222
|
EVP Research | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
Oct 05, 2020 |
Director
Trans History: 381
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 9,212 | -- | -- |
Sep 24, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Bona fide gift | 50 | -- | -- |
Sep 22, 2020 |
Director
Trans History: 466
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,610 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.